Patrick Baumhof, Dr (he/him/his)

SVP Technology
CureVac AG
Tuebingen, Germany

Patrick Baumhof, PhD
Senior Vice President Technology
trained in Chemistry, at the University of Leipzig. His scientific expertise includes chemistry, pharmaceutical sciences and immunology. He joined CureVac in July 2007 when he was responsible for the development and preclinical testing of new formulations for mRNA vaccines and therapeutics. He is inventor of several patents and he co-authored several publications on mRNA technology. Currently he is Senior Vice President Technology at CureVac AG.

Presentation(s):

• Translational Science and Entrepreneurship Event: mRNA/LNP Therapeutics and Vaccines in Global Healthcare

  Tuesday, July 25, 2023
  2:00 PM – 3:00 PM US PST